Check out Leigha’s video.

120 likes, 11 comments. “Miracle Obesity Treatment⁉️ 📢 Exciting News for Weight Loss! The FDA has granted approval to Eli Lilly for marketing their medication, tirzepatide, under a new brand name, Zepbound, for weight loss. While previously used off-label, this approval allows the company to officially sell and market Zepbound as a weight loss treatment. The medication will be available in the U.S. by the end of the year, offering a more affordable option compared to its competitors. This breakthrough brings hope to individuals struggling with obesity and seeking effective weight management solutions. 🔹 Zepbound will be sold at a lower list price than semaglutide competitors. 🔹 Participants in a trial who received the highest approved dose of Zepbound experienced an 18% reduction in body weight compared to placebo. 🔹 The FDA’s approval addresses the growing need for effective #weightlosstreatments in light of increasing obesity rates. 🔹 Research suggests that Zepbound may outperfo